Insider · CIK 0001845677
Jason R Kelly
officerdirector
Files at DNA (Ginkgo Bioworks Holdings, Inc.). First filing Oct 13, 2023, latest Apr 10, 2026.
In brief
Jason R Kelly files SEC Form 4 as officer and director at DNA (Ginkgo Bioworks Holdings, Inc.). Since Oct 13, 2023, Jason R Kelly has reported 0 open-market buys worth $0 and 13 open-market sells worth $5.0M, the latest filed on Apr 10, 2026.
A track record needs three past buys with six months of prices behind them; Jason R Kelly has 0, so none is measured yet.
The newest scored trade: sold $1.4M of DNA on Apr 8, 2026, filed Apr 10, 2026, scored 50 (moderate). In the last 12 months: 0 buys worth $0 and 1 sell worth $1.4M.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 13
$0 bought, $5.0M sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
DNA: Ginkgo Bioworks Holdings, Inc.
DNAOct 12, 2026 · close 11.79
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 50Moderate | Ginkgo Bioworks Holdings, Inc. | $1.4M 206,782 shares | -40% | +26% from low-57% from high | |
| 24Weak | Ginkgo Bioworks Holdings, Inc. | $310k 200,000 shares | -5% | +35% from low-39% from high | |
| 25Weak | Ginkgo Bioworks Holdings, Inc. | $353k 200,000 shares | -5% | +49% from low-33% from high | |
| 24Weak | Ginkgo Bioworks Holdings, Inc. | $297k 200,000 shares | -4% | +26% from low-43% from high | |
| 23Weak | Ginkgo Bioworks Holdings, Inc. | $264k 200,000 shares | -4% | +14% from low-49% from high | |
| 24Weak | Ginkgo Bioworks Holdings, Inc. | $281k 200,000 shares | -4% | +22% from low-45% from high | |
| 24Weak | Ginkgo Bioworks Holdings, Inc. | $282k 200,000 shares | -4% | +21% from low-46% from high | |
| 24Weak | Ginkgo Bioworks Holdings, Inc. | $299k 200,000 shares | -4% | +37% from low-42% from high | |
| 24Weak | Ginkgo Bioworks Holdings, Inc. | $279k 200,000 shares | -4% | +31% from low-48% from high | |
| 24Weak | Ginkgo Bioworks Holdings, Inc. | $286k 200,000 shares | -4% | +19% from low-52% from high | |
| 24Weak | Ginkgo Bioworks Holdings, Inc. | $294k 200,000 shares | -3% | +26% from low-49% from high | |
| 25Weak | Ginkgo Bioworks Holdings, Inc. | $330k 200,000 shares | -3% | +45% from low-42% from high | |
| 25Weak | Ginkgo Bioworks Holdings, Inc. | $341k 200,000 shares | -3% | +54% from low-41% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Apr 9, 2026 | DNA Ginkgo Bioworks Holdings, Inc. | 109,767 0.22% of outstanding | $702k | Apr 9, 2026 | $672k |
| Apr 8, 2026 | DNA Ginkgo Bioworks Holdings, Inc. | 97,015 0.19% of outstanding | $672k | Apr 8, 2026 | none |
| Jan 4, 2024 | DNA Ginkgo Bioworks Holdings, Inc. | 100,000 0.01% of outstanding | $155k | Jan 4, 2024 | $3.8M |
| Jan 3, 2024 | DNA Ginkgo Bioworks Holdings, Inc. | 100,000 0.01% of outstanding | $165k | Jan 3, 2024 | $3.6M |
| Dec 21, 2023 | DNA Ginkgo Bioworks Holdings, Inc. | 100,000 0.01% of outstanding | $176k | Dec 21, 2023 | $4.0M |
| Dec 20, 2023 | DNA Ginkgo Bioworks Holdings, Inc. | 100,000 0.01% of outstanding | $180k | Dec 20, 2023 | $4.0M |
| Dec 14, 2023 | DNA Ginkgo Bioworks Holdings, Inc. | 100,000 0.01% of outstanding | $148k | Dec 14, 2023 | $4.0M |
| Dec 13, 2023 | DNA Ginkgo Bioworks Holdings, Inc. | 100,000 0.01% of outstanding | $133k | Dec 13, 2023 | $4.1M |
| Dec 7, 2023 | DNA Ginkgo Bioworks Holdings, Inc. | 100,000 0.01% of outstanding | $131k | Dec 7, 2023 | $4.2M |
| Dec 6, 2023 | DNA Ginkgo Bioworks Holdings, Inc. | 100,000 0.01% of outstanding | $135k | Dec 6, 2023 | $4.3M |
| Nov 30, 2023 | DNA Ginkgo Bioworks Holdings, Inc. | 100,000 0.01% of outstanding | $142k | Nov 30, 2023 | $4.6M |
| Nov 29, 2023 | DNA Ginkgo Bioworks Holdings, Inc. | 100,000 0.01% of outstanding | $146k | Nov 29, 2023 | $4.4M |
| Nov 24, 2023 | DNA Ginkgo Bioworks Holdings, Inc. | 100,000 0.01% of outstanding | $139k | Nov 24, 2023 | $4.5M |
| Nov 22, 2023 | DNA Ginkgo Bioworks Holdings, Inc. | 100,000 0.01% of outstanding | $145k | Nov 22, 2023 | $4.5M |
| Nov 16, 2023 | DNA Ginkgo Bioworks Holdings, Inc. | 100,000 0.01% of outstanding | $152k | Nov 16, 2023 | $4.7M |
| Nov 15, 2023 | DNA Ginkgo Bioworks Holdings, Inc. | 100,000 0.01% of outstanding | $145k | Nov 15, 2023 | $4.5M |
| Nov 9, 2023 | DNA Ginkgo Bioworks Holdings, Inc. | 100,000 0.01% of outstanding | $139k | Nov 9, 2023 | $4.8M |
| Nov 8, 2023 | DNA Ginkgo Bioworks Holdings, Inc. | 100,000 0.01% of outstanding | $156k | Nov 8, 2023 | $4.6M |
| Nov 2, 2023 | DNA Ginkgo Bioworks Holdings, Inc. | 100,000 0.01% of outstanding | $141k | Nov 2, 2023 | $4.9M |
| Nov 1, 2023 | DNA Ginkgo Bioworks Holdings, Inc. | 100,000 0.01% of outstanding | $137k | Nov 1, 2023 | $4.8M |
| Oct 26, 2023 | DNA Ginkgo Bioworks Holdings, Inc. | 100,000 0.01% of outstanding | $146k | Oct 26, 2023 | $5.1M |
| Oct 25, 2023 | DNA Ginkgo Bioworks Holdings, Inc. | 100,000 0.01% of outstanding | $154k | Oct 25, 2023 | $4.9M |
| Oct 19, 2023 | DNA Ginkgo Bioworks Holdings, Inc. | 100,000 0.01% of outstanding | $165k | Oct 19, 2023 | $5.3M |
| Oct 18, 2023 | DNA Ginkgo Bioworks Holdings, Inc. | 100,000 0.01% of outstanding | $173k | Oct 18, 2023 | $5.1M |
| Oct 12, 2023 | DNA Ginkgo Bioworks Holdings, Inc. | 100,000 0.01% of outstanding | $176k | Oct 12, 2023 | $5.4M |
Transactions
Every row this insider has filed, 33 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 28, 2026 | DNA Ginkgo Bioworks Holdings, Inc. | AGrant or award Restricted Stock Unitsderivative | +74,258 | - | - | 74,258 | Jul 30, 2026 |
| Jul 28, 2026 | DNA Ginkgo Bioworks Holdings, Inc. | AGrant or award Restricted Stock Unitsderivative | +309,467 | - | - | 309,467 | Jul 30, 2026 |
| Apr 7, 2026 | DNA Ginkgo Bioworks Holdings, Inc. | MOption exercise Class A Common Stock | +212,949 | - | - | 310,316 | Apr 10, 2026 |
| Apr 8, 2026 | DNA Ginkgo Bioworks Holdings, Inc. | MOption exercise Class A Common Stock | +212,949 | - | - | 523,265 | Apr 10, 2026 |
| Apr 8, 2026 | DNA Ginkgo Bioworks Holdings, Inc. | SOpen-market sale Class A Common Stock | -97,015 | $6.93 | $672k | 426,250 | Apr 10, 2026 |
| Apr 9, 2026 | DNA Ginkgo Bioworks Holdings, Inc. | SOpen-market sale Class A Common Stock | -109,767 | $6.40 | $702k | 316,483 | Apr 10, 2026 |
| Apr 7, 2026 | DNA Ginkgo Bioworks Holdings, Inc. | MOption exercise Performance-Based Restricted Stock Unitderivative | -212,949 | - | - | 212,949 | Apr 10, 2026 |
| Apr 8, 2026 | DNA Ginkgo Bioworks Holdings, Inc. | MOption exercise Performance-Based Restricted Stock Unitderivative | -212,949 | - | - | 0 | Apr 10, 2026 |
| Apr 25, 2024 | DNA Ginkgo Bioworks Holdings, Inc. | AGrant or award Stock Optionderivative | +5,000,000 | $0.00 | $0 | 5,000,000 | Apr 29, 2024 |
| Jan 3, 2024 | DNA Ginkgo Bioworks Holdings, Inc. | SOpen-market sale Class A Common Stock10b5-1 | -100,000 | $1.54 | $154k | 3,994,680 | Jan 5, 2024 |
| Jan 4, 2024 | DNA Ginkgo Bioworks Holdings, Inc. | SOpen-market sale Class A Common Stock10b5-1 | -100,000 | $1.56 | $156k | 3,894,680 | Jan 5, 2024 |
| Dec 20, 2023 | DNA Ginkgo Bioworks Holdings, Inc. | SOpen-market sale Class A Common Stock10b5-1 | -100,000 | $1.79 | $179k | 4,194,680 | Dec 22, 2023 |
| Dec 21, 2023 | DNA Ginkgo Bioworks Holdings, Inc. | SOpen-market sale Class A Common Stock10b5-1 | -100,000 | $1.74 | $174k | 4,094,680 | Dec 22, 2023 |
| Dec 13, 2023 | DNA Ginkgo Bioworks Holdings, Inc. | SOpen-market sale Class A Common Stock10b5-1 | -99,020 | $1.34 | $133k | 4,395,660 | Dec 15, 2023 |
| Dec 14, 2023 | DNA Ginkgo Bioworks Holdings, Inc. | SOpen-market sale Class A Common Stock10b5-1 | -100,980 | $1.63 | $164k | 4,294,680 | Dec 15, 2023 |
| Dec 6, 2023 | DNA Ginkgo Bioworks Holdings, Inc. | SOpen-market sale Class A Common Stock10b5-1 | -100,000 | $1.32 | $132k | 4,594,680 | Dec 8, 2023 |
| Dec 7, 2023 | DNA Ginkgo Bioworks Holdings, Inc. | SOpen-market sale Class A Common Stock10b5-1 | -100,000 | $1.31 | $131k | 4,494,680 | Dec 8, 2023 |
| Nov 29, 2023 | DNA Ginkgo Bioworks Holdings, Inc. | SOpen-market sale Class A Common Stock10b5-1 | -100,000 | $1.45 | $145k | 4,794,680 | Dec 1, 2023 |
| Nov 30, 2023 | DNA Ginkgo Bioworks Holdings, Inc. | SOpen-market sale Class A Common Stock10b5-1 | -100,000 | $1.35 | $135k | 4,694,680 | Dec 1, 2023 |
| Nov 22, 2023 | DNA Ginkgo Bioworks Holdings, Inc. | SOpen-market sale Class A Common Stock10b5-1 | -100,000 | $1.40 | $140k | 4,994,680 | Nov 27, 2023 |
| Nov 24, 2023 | DNA Ginkgo Bioworks Holdings, Inc. | SOpen-market sale Class A Common Stock10b5-1 | -100,000 | $1.41 | $141k | 4,894,680 | Nov 27, 2023 |
| Nov 15, 2023 | DNA Ginkgo Bioworks Holdings, Inc. | SOpen-market sale Class A Common Stock10b5-1 | -100,000 | $1.54 | $154k | 5,194,680 | Nov 17, 2023 |
| Nov 16, 2023 | DNA Ginkgo Bioworks Holdings, Inc. | SOpen-market sale Class A Common Stock10b5-1 | -100,000 | $1.45 | $145k | 5,094,680 | Nov 17, 2023 |
| Nov 8, 2023 | DNA Ginkgo Bioworks Holdings, Inc. | SOpen-market sale Class A Common Stock10b5-1 | -100,000 | $1.50 | $150k | 5,394,680 | Nov 13, 2023 |
| Nov 9, 2023 | DNA Ginkgo Bioworks Holdings, Inc. | SOpen-market sale Class A Common Stock10b5-1 | -100,000 | $1.29 | $129k | 5,294,680 | Nov 13, 2023 |
| Nov 1, 2023 | DNA Ginkgo Bioworks Holdings, Inc. | SOpen-market sale Class A Common Stock10b5-1 | -100,000 | $1.34 | $134k | 5,594,680 | Nov 3, 2023 |
| Nov 2, 2023 | DNA Ginkgo Bioworks Holdings, Inc. | SOpen-market sale Class A Common Stock10b5-1 | -100,000 | $1.52 | $152k | 5,494,680 | Nov 3, 2023 |
| Oct 25, 2023 | DNA Ginkgo Bioworks Holdings, Inc. | SOpen-market sale Class A Common Stock10b5-1 | -100,000 | $1.48 | $148k | 5,794,680 | Oct 27, 2023 |
| Oct 26, 2023 | DNA Ginkgo Bioworks Holdings, Inc. | SOpen-market sale Class A Common Stock10b5-1 | -100,000 | $1.46 | $146k | 5,694,680 | Oct 27, 2023 |
| Oct 18, 2023 | DNA Ginkgo Bioworks Holdings, Inc. | SOpen-market sale Class A Common Stock10b5-1 | -100,000 | $1.69 | $169k | 5,994,680 | Oct 20, 2023 |
| Oct 19, 2023 | DNA Ginkgo Bioworks Holdings, Inc. | SOpen-market sale Class A Common Stock10b5-1 | -100,000 | $1.61 | $161k | 5,894,680 | Oct 20, 2023 |
| Oct 11, 2023 | DNA Ginkgo Bioworks Holdings, Inc. | SOpen-market sale Class A Common Stock10b5-1 | -100,000 | $1.76 | $176k | 6,194,680 | Oct 13, 2023 |
| Oct 12, 2023 | DNA Ginkgo Bioworks Holdings, Inc. | SOpen-market sale Class A Common Stock10b5-1 | -100,000 | $1.66 | $166k | 6,094,680 | Oct 13, 2023 |
Questions about Jason R Kelly
Answered from the filings on this page, as of the latest one.
Is Jason R Kelly buying or selling?
In the last 12 months Jason R Kelly reported 0 open-market buys worth $0 and 1 open-market sell worth $1.4M on SEC Form 4; the latest was sold $1.4M of DNA on Apr 8, 2026. Grants, option exercises and tax withholding are not counted.
How did Jason R Kelly's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Jason R Kelly has 0.
Where does Jason R Kelly file Form 4?
Jason R Kelly has filed Form 4 at DNA (Ginkgo Bioworks Holdings, Inc.) as See remarks. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.